PALYTOXIN PRODRUG SYNTHESIS, PURIFICATION, AND ANALYSES
海藻毒素前药的合成、纯化和分析
基本信息
- 批准号:2096080
- 负责人:
- 金额:$ 22.45万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:1991
- 资助国家:美国
- 起止时间:1991-07-01 至 1994-12-31
- 项目状态:已结题
- 来源:
- 关键词:amidases amides animal extract animal poison antineoplastics aquatic organism chemical synthesis cytotoxicity drug design /synthesis /production enzyme activity enzyme substrate analog high performance liquid chromatography immunoconjugates method development monoclonal antibody nuclear magnetic resonance spectroscopy phenylacetates prodrugs protein purification thin layer chromatography tissue /cell culture ultraviolet spectrometry
项目摘要
During Phase I research, two palytoxin-derived prodrugs were prepared. The
prodrugs were up to 1000-fold less cytotoxic to cells in culture than
palytoxin. In the presence of activating enzyme, full conversion of the
prodrug to palytoxin was demonstrated. Anti-tumor monoclonal antibody
conjugates of the activating enzyme conferred antigen-selective
cytotoxicity to the prodrugs of up to 100-fold, against cells in culture.
In mixed populations of antigen-positive and -negative cells, a potent
"bystander-cell" killing effect was observed. This is the first marine
toxin derivative used as a prodrug.
The Phase II research effort will further optimize synthetic, purification,
and analytical methodology for palytoxin-derived prodrugs. Additional
congeners of the palytoxin derivatives will be prepared and evaluated
against cells in culture. Preclinical antitumor activity will be
investigated under a collaborative research agreement.
在第一阶段研究期间,制备了两种海藻毒素衍生的前药。 这
前药对培养细胞的细胞毒性比
海藻毒素。 在活化酶的存在下,
证明了水萼毒素的前药。 抗肿瘤单克隆抗体
赋予抗原选择性的活化酶的缀合物
前药对培养细胞的细胞毒性高达 100 倍。
在抗原阳性和抗原阴性细胞的混合群体中,一种有效的
观察到“旁观者细胞”杀伤作用。 这是第一艘海军
用作前药的毒素衍生物。
二期研究工作将进一步优化合成、纯化、
以及海藻毒素衍生的前药的分析方法。 额外的
将制备并评估海萼毒素衍生物的同系物
对抗培养中的细胞。 临床前抗肿瘤活性将
根据合作研究协议进行调查。
项目成果
期刊论文数量(1)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Lophozozymus pictor toxin: a fluorescent structural isomer of palytoxin.
Lophozzymus pictor 毒素:海藻毒素的荧光结构异构体。
- DOI:10.1016/0041-0101(95)00075-w
- 发表时间:1995
- 期刊:
- 影响因子:0
- 作者:Lau,CO;Tan,CH;Khoo,HE;Yuen,R;Lewis,RJ;Corpuz,GP;Bignami,GS
- 通讯作者:Bignami,GS
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Gary Steven Bignami其他文献
Gary Steven Bignami的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Gary Steven Bignami', 18)}}的其他基金
DEVICE FOR RAPID DETECTION OF DENGUE--SPECIFIC ANTIBODY
登革热特异性抗体快速检测装置
- 批准号:
2005001 - 财政年份:1997
- 资助金额:
$ 22.45万 - 项目类别:
ORGANIC PHASE IMMUNOASSAY FOR CHLORINATED DIBENZODIOXINS
氯化二苯并二恶英的有机相免疫测定法
- 批准号:
3496687 - 财政年份:1992
- 资助金额:
$ 22.45万 - 项目类别:
BISPECIFIC ANTIBODY FOR DIRECTED DELIVERY OF TAXOL
用于紫杉醇定向递送的双特异性抗体
- 批准号:
3493114 - 财政年份:1992
- 资助金额:
$ 22.45万 - 项目类别:
PALYTOXIN PRODRUG SYNTHESIS, PURIFICATION, AND ANALYSES
海藻毒素前药的合成、纯化和分析
- 批准号:
3506879 - 财政年份:1991
- 资助金额:
$ 22.45万 - 项目类别:
BISPECIFIC ANTIBODY FOR DIRECTED DELIVERY OF PALYTOXIN
用于定向递送海藻毒素的双特异性抗体
- 批准号:
3492507 - 财政年份:1991
- 资助金额:
$ 22.45万 - 项目类别:
PALYTOXIN PRODUG ACTIVATION BY ANTIBODY-LINKED ENZYME
抗体连接酶激活海藻毒素产物
- 批准号:
3492816 - 财政年份:1991
- 资助金额:
$ 22.45万 - 项目类别:
相似海外基金
Collaborative Research: NSF-DFG: CAS: Electrochemical Hydrogenation of Amides and Esters
合作研究:NSF-DFG:CAS:酰胺和酯的电化学氢化
- 批准号:
2140205 - 财政年份:2022
- 资助金额:
$ 22.45万 - 项目类别:
Standard Grant
Collaborative Research: NSF-DFG: CAS: Electrochemical Hydrogenation of Amides and Esters
合作研究:NSF-DFG:CAS:酰胺和酯的电化学氢化
- 批准号:
2140196 - 财政年份:2022
- 资助金额:
$ 22.45万 - 项目类别:
Standard Grant
Atroposelective Synthesis of Hindered Amides - Exploration of Synthetic Peptide Catalysts -
受阻酰胺的天体选择性合成-合成肽催化剂的探索-
- 批准号:
504378162 - 财政年份:2022
- 资助金额:
$ 22.45万 - 项目类别:
WBP Fellowship
Development of Peptide Chemical Modification Enabled by N-Halogenation of Amides
酰胺 N-卤化实现的肽化学修饰的发展
- 批准号:
22H02743 - 财政年份:2022
- 资助金额:
$ 22.45万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Modulating Signaling Endocannabinoids and Fatty Acid Amides
调节信号传导内源性大麻素和脂肪酸酰胺
- 批准号:
10532252 - 财政年份:2021
- 资助金额:
$ 22.45万 - 项目类别:
CAREER: SusChEM: Iron Catalysts for the Reduction of Amides
职业:SusChEM:用于还原酰胺的铁催化剂
- 批准号:
2146728 - 财政年份:2021
- 资助金额:
$ 22.45万 - 项目类别:
Continuing Grant
Modulating Signaling Endocannabinoids and Fatty Acid Amides
调节信号传导内源性大麻素和脂肪酸酰胺
- 批准号:
10399712 - 财政年份:2021
- 资助金额:
$ 22.45万 - 项目类别:
Nickel-Catalyzed Alpha-Arylation of Secondary Amides
镍催化仲酰胺的α-芳基化
- 批准号:
558383-2020 - 财政年份:2020
- 资助金额:
$ 22.45万 - 项目类别:
Canadian Graduate Scholarships Foreign Study Supplements
Function of primary fatty acid amides as lipid mediators
伯脂肪酸酰胺作为脂质介质的功能
- 批准号:
20K21285 - 财政年份:2020
- 资助金额:
$ 22.45万 - 项目类别:
Grant-in-Aid for Challenging Research (Exploratory)
Improving selectivity in Ni-catalyzed activation of amides
提高镍催化酰胺活化的选择性
- 批准号:
518319-2018 - 财政年份:2020
- 资助金额:
$ 22.45万 - 项目类别:
Postgraduate Scholarships - Doctoral